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Coronary Computed
Tomography Angiography
The Challenge of Coronary Calcium*
Steven E. Nissen, MD
Cleveland, Ohio
In this issue of the Journal, Arbab-Zadeh et al. (1) report on
the influence of calcification and the pre-test likelihood of
disease on the diagnostic accuracy of coronary computed
tomography angiography (CTA) in a small multicenter
study (CORE-64 [Coronary Artery Evaluation Using 64-
Row Multidetector Computed Tomography Angiogra-
phy]). Their report provides valuable insights into the
importance of coronary calcification as an unresolved limi-
tation of CTA. The original CORE-64 report pre-specified
exclusion of patients with a calcium score 600 Agatston
units, a criterion that eliminated 89 of 405 patients (22%)
from the analysis (2). In the current paper (1), the authors
have appropriately included such patients, documenting an
important limitation in the diagnostic accuracy of CTA
when applied in an unselected population. For patients with
Agatston score 600, the performance of CTA was unfa-
vorable. Regardless of pre-test likelihood of disease, the
negative predictive value was 0.50 for quantitative assess-
ment of CAD and 0.63 for visual assessment.
See page 379
The current study also demonstrates that lesser degrees of
coronary calcification can impair the diagnostic accuracy of
coronary CTA. Among patients with any calcification score
0, the negative predictive value of CTA in patients with a
high pre-test probability of disease ranged from approxi-
mately 50% to 60%. Similar deterioration in performance
was observed for patients with coronary calcification and an
intermediate probability of disease, particularly if the Agat-
ston score exceeded 100. The careful analysis provided by
the current study will be valuable to practitioners consider-
ing how to optimally apply coronary CTA in routine clinical
practice. These findings suggest that CTA, using current
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paper to disclose.technology, probably should not be used for diagnostic
purposes in patients with substantial coronary calcification.
Understanding the exclusion criteria in any imaging study
is critical to interpretation of the findings. The original
CORE-64 study report, like several similar studies, was
designed to evaluate coronary CTA under reasonably ideal
conditions. The list of exclusion criteria included prior
cardiac surgery, creatinine levels 1.5 mg/dl, atrial fibrilla-
tion, class III or IV heart failure, coronary intervention
within the past 6 months, intolerance to beta-blockers, and
a body mass index 40 kg/m2. It is useful to consider the
profile of patients undergoing catheterization for suspected
coronary disease in the United States. The median body
mass index of patients undergoing catheterization in recent
studies exceeds 30 kg/m2, with substantial numbers exceed-
ing 40 kg/m2. The prevalence of atrial fibrillation in the
U.S. population is substantial and increases with age,
reaching nearly 10% by 80 years of age (3). Approximately
11% of American over the age of 60 years have a creatinine
level 1.6 mg/dl (4). The prevalence of chronic obstructive
pulmonary disease is also high among patients undergoing
catheterization, suggesting that intolerance to beta-blockers
will result in exclusion of additional patients.
For ethical reasons, the CORE-64 study population only
included patients for whom cardiac catheterization was
deemed clinically indicated. Ninety-eight patients (26%)
actually had known coronary disease. Such patients repre-
sent a high-risk subset of those seeking medical care for
chest pain of suspected cardiac origin, which likely explains
the relatively high prevalence of coronary calcification. The
symptoms exhibited by these patients were sufficient to
warrant the risk and expense of cardiac catheterization. In
this population, we must consider whether the results of
CTA would allow deferral of coronary angiography. In the
current analysis (1), the negative predictive value of coronary
CTA for patients with known CAD was approximately
0.50. In the group with an intermediate probability of
disease, the sensitivity and specificity were more acceptable,
with false positive and false negative rates in the 10% to 15%
range. Therefore, as documented in the current study (1),
error rates remain too high to recommend use of CTA as an
alternative to cardiac catheterization or imaging stress tests
in patients with a high probability of CAD.
In determining when to use coronary CTA in clinical
practice, we must also consider the potential harm produced
by coronary CTA imaging as currently practiced. The doses
of radiation are substantial, although gradually falling at
sophisticated centers with technical improvements in study
methods. The median radiation dose in a large multicenter
study of CTA was 12 mSv, equivalent to 600 chest
radiographs (5). The CORE-64 study authors report
slightly higher doses, ranging from 12 to 15 mSv, with a top
limit of 20 mSv. By comparison, most studies of conven-
tional diagnostic coronary angiography report a dose range
from 2 to 6 mSv. Accordingly, the radiation dosage from
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likely effect of such doses has been debated, but it is
generally accepted that there is no safe dosage of radiation
and that exposure to current dose levels will predictably
increase rates of malignancy. Many patients will likely
receive numerous CTA studies and other radiographic and
nuclear imaging procedures for cardiac and noncardiac
indications. Accordingly, the patient care benefits of any
imaging procedure that exposes patients to ionizing radia-
tion must clearly exceed the hazards.
In addition to the problem of coronary calcification
demonstrated by the current study, it must also be recog-
nized that the presence of a coronary stenosis per se does not
accurately determine the physiological consequences of such
lesions. The presence or absence of a 50% stenosis in the
coronary arteries does not define whether revascularization
is appropriate or inappropriate. Symptoms and the presence
of reversible ischemia are the pivotal factors determining the
appropriateness of coronary interventions. Accordingly, in
the assessment of patients with an intermediate probability
of CAD, coronary CTA remains less useful than imaging
stress tests. For such patients, we are less interested in the
presence of stenosis than evidence documenting whether
obstructions are ischemia-producing. Accordingly, an ab-
normal CTA may require another imaging procedure in
many patients to determine the physiologic impact of
observed stenoses.
In future studies, what proof of benefit should we
demand of CTA? To justify widespread usage, the tech-
nique must be shown to improve relevant patient outcomes,
including survival, improve the accuracy of diagnoses, or
substantially reduce health care costs. None of these benefits
has yet been demonstrated convincingly for coronary CTA.
Nonetheless, CT coronary imaging continues to grow in
utilization, often fueled by weekend “training” courses
designed to achieve certification for participants. Some
practitioners have purchased devices to enable in-office
imaging of patients, a situation that creates incentives for
over-use. Unfortunately, for some patients, an abnormal CT
scan rather than symptoms or evidence of ischemia, are the
primary driver for invasive procedures, including coronary
interventions.
A case recently reported in the Archives of Internal
Medicine poignantly illustrates the risks of decision making
overly influenced by the presence of a stenosis in thepresence of coronary calcification (6). We describe a 52-
year-old nurse with atypical chest pain and a low pre-test
probability of disease, who underwent CTA to “reassure”
her. The presence of a difficult to visualize calcified left
anterior descending artery lesion led to cardiac catheteriza-
tion, which resulted in a catastrophic dissection of the left
main coronary artery, eventually leading to heart transplan-
tation. This case dramatically highlights the importance of
understanding how coronary calcification limits the accuracy
of CTA.
The current study reported by Arbab-Zadeh et al. (1)
helps us understand what must be expected in subsequent
studies examining the clinical utility of CTA. Future studies
must evaluate important clinical outcomes, not just the
extent of stenoses, in a wide spectrum of patients not
selected because they represent ideal candidates for CTA.
Pending such evaluation, coronary imaging using CTA
should be used sparingly, with full recognition of the
radiation burdens and risks of misdiagnosis.
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